126 related articles for article (PubMed ID: 10396858)
21. Anaplastic carcinoma of the thyroid.
Hadar T; Mor C; Shvero J; Levy R; Segal K
Eur J Surg Oncol; 1993 Dec; 19(6):511-6. PubMed ID: 8270035
[TBL] [Abstract][Full Text] [Related]
22. [Undifferentiated thyroid cancer: improved therapeutic results following initial radical intervention and early postoperative radiotherapy].
Scheumann GF; Wegener G; Kemnitz J; Dralle H
Helv Chir Acta; 1990 Jun; 57(1):57-60. PubMed ID: 2228687
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
25. [The role of external radiotherapy in the treatment of medullary carcinoma of the thyroid].
Costa MA; Sousa O; Azevedo I; Castro C; Fernandes T; Vieira E
Acta Med Port; 1998 Jun; 11(6):539-42. PubMed ID: 9773532
[TBL] [Abstract][Full Text] [Related]
26. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
Junor EJ; Paul J; Reed NS
Eur J Surg Oncol; 1992 Apr; 18(2):83-8. PubMed ID: 1582515
[TBL] [Abstract][Full Text] [Related]
28. [Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987].
Kuijpens JL; Hoekstra OS; Hamming JF; Haak HR; Ribot JG; Coebergh JW
Ned Tijdschr Geneeskd; 2002 Mar; 146(10):473-7. PubMed ID: 11913113
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
[TBL] [Abstract][Full Text] [Related]
30. Advanced thyroid carcinoma: an experience of 385 cases.
Freschi G; Landi L; Castagnoli A; Taddei A; Bechi P; Bucciarelli G
Eur J Surg Oncol; 2006 Jun; 32(5):577-82. PubMed ID: 16644177
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of results after repeated radical surgery for differentiated thyroid cancer].
Czarniecka A; Włoch J; Turska M
Wiad Lek; 2001; 54 Suppl 1():218-24. PubMed ID: 12182029
[TBL] [Abstract][Full Text] [Related]
32. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
34. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
35. Treatment of locally aggressive well-differentiated thyroid cancer.
Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
Brierley J; Tsang R; Panzarella T; Bana N
Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
[TBL] [Abstract][Full Text] [Related]
37. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
38. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
Wiebe V; Schneider C; Franke HD
Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
[TBL] [Abstract][Full Text] [Related]
39. Locally advanced thyroid cancer: therapeutic options.
Avenia N; Ragusa M; Monacelli M; Calzolari F; Daddi N; Di Carlo L; Semeraro A; Puma F
Chir Ital; 2004; 56(4):501-8. PubMed ID: 15452988
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
